XML 30 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814
DESCRIPTION OF BUSINESS
3 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
DESCRIPTION OF BUSINESS

NOTE 1.  DESCRIPTION OF BUSINESS

 

 The Company is incorporated in the state of Nevada.  The Company has three subsidiaries, PC Group, Inc. (formerly, Park City Group, Inc., a Delaware corporation), a Utah Corporation (98.76% owned), Park City Group, Inc., (formerly, Prescient Applied Intelligence, Inc.), a wholly owned Delaware Corporation, and ReposiTrak, Inc., a wholly owned Utah corporation (“ReposiTrak”).  All intercompany transactions and balances have been eliminated in consolidation.

 

The Company designs, develops, markets and supports proprietary software products. These products are designed for businesses having multiple locations to assist in the management of business operations on a daily basis and communicate results of operations in a timely manner.   As a result of the acquisition of ReposiTrak in June 2015, the Company also provides food retailers and suppliers with a robust solution to help them protect their brands and remain in compliance with the rapidly evolving regulations in the Food Safety Modernization Act (“FSMA”). Additionally, ReposiTrak enables traceability of products and their ingredients as they move between trading partners. 

 

The Company has also built a consulting practice for business improvement that centers on the Company’s proprietary software products. The principal markets for the Company's products are multi-store retail and convenience store chains, branded food manufacturers, suppliers and distributors, and manufacturing companies, which have operations in North America, Europe, Asia and the Pacific Rim.

 

Recent Developments

  

 During the year ended June 30, 2015, the Company entered into agreements with each of the stockholders of ReposiTrak, including Leavitt Partners, LP and LP Special Asset 4, LLC, to acquire all of the outstanding capital stock of ReposiTrak (the “ReposiTrak Shares”) in exchange for shares of the Company’s common stock, par value $0.01 per share (the “ReposiTrak Acquisition”).   On June 30, 2015, the Company consummated the ReposiTrak Acquisition.  As a result, ReposiTrak became a 100% owned subsidiary of the Company.   The ReposiTrak Acquisition creates an opportunity for the Company to add customers by expanding the services we offer to our existing customer base, to ReposiTrak customers.

 

 We have accounted for the acquisition as the purchase of a business.  The assets acquired and the liabilities assumed of ReposiTrak have been recorded at their respective fair values.  The excess of the purchase price over the fair value of net tangible and identifiable intangible assets acquired was recorded as goodwill.  Goodwill is attributed to buyer-specific value resulting from expected synergies, including long-term cost savings, as well as industry relationships which are not included in the fair values of assets.  Goodwill will not be amortized.

 

 The purchase price consisted of 873,438 shares of our common stock.  The fair value of the shares issued was $10,821,897 and was determined using the closing price of our common stock on June 30, 2015.  The price paid to acquire ReposiTrak was $10,830,897, approximately $9,000 of which was for direct transaction costs associated with the issuance of equity.    The net acquisition cost of $10,799,778, which excludes $31,119 of cash acquired from ReposiTrak, was allocated based on their estimated fair value of the assets acquired and liabilities assumed, as follows:

 

    Originally Filed     Adjustments*     Finalized Values  
Receivables   $ 152,340     $ -     $ 152,340  
Prepaid expenses     17,500       -       17,500  
Customer relationships     2,006,951       (692,951 )     1,314,000  
Goodwill     15,385,002       692,951       16,077,953  
Accounts payable     (128,126 )     -       (128,126
Deferred revenue     (598,232 )     -       (598,232
Net assets acquired     16,835,435       -       16,835,435  
Common stock issued     10,821,897       -       10,821,897  
Receivables eliminated in consolidation     6,035,657       -       6,035,657  
                         
Cash received in acquisition   $ 22,119     $ -     $ 22,119  

 

*Adjustments due to finalization of valuation. The adjusted values are reflected retrospectively in the balance sheet for the period ended June 30, 2015.

 

 

-5-


Table of Contents

 

The accompanying audited consolidated financial statements of the Company as of and for the year ended June 30, 2015 contain the results of operations of ReposiTrak from June 30, 2015. 

 

Unaudited pro-forma results of operations for the twelve months ended June 30, 2015 and 2014, as though ReposiTrak had been acquired as of July 1, 2013, are as follows:

 

    Three Months Ended              
   

Sep 30,

2014

   

Dec 31,

2014

   

Mar 31,

2015

   

Jun 30,

2015

   

Year Ended

2015

   

Year Ended

2014

 
Revenue   $ 2,826,813     $ 2,932,825     $ 2,870,646     $ 2,941,511     $ 11,571,795     $ 9,777,431  
Loss from Operations   $ (1,046,986   $ (1,290,524   $ (1,302,437   $ (3,222,538   $ (6,862,485 )   $ (5,232,552 )
Net Loss   $ (1,049,834   $ (1,317,510   $ (1,317,858   $ (3,241,545   $ (6,926,747 )   $ (5,303,773 )
Net Loss Applicable to Common Shareholders   $ (1,204,307   $ (1,471,983   $ (3,595,537   $ (3,365,721   $ (9,637,548 )   $ (5,921,664 )
Basic and Diluted EPS   $ (0.07   $ (0.08   $ (0.20   $ (0.18   $ (0.53 )   $ (0.34 )

 

Basis of Financial Statement Presentation

 

The interim financial information of the Company as of September 30, 2015 and for the three months ended September 30, 2015 and 2014 is unaudited, and the balance sheet as of June 30, 2015 is derived from audited financial statements. The accompanying condensed consolidated financial statements have been prepared in accordance with U. S. generally accepted accounting principles for interim financial statements. Accordingly, they omit or condense notes and certain other information normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles. The accounting policies followed for quarterly financial reporting conform with the accounting policies disclosed in Note 2 to the Notes to Financial Statements included in our Annual Report on Form 10-K for the year ended June 30, 2015. In the opinion of management, all adjustments necessary for a fair presentation of the financial information for the interim periods reported have been made. All such adjustments are of a normal recurring nature. The results of operations for the three months ended September 30, 2015 are not necessarily indicative of the results that can be expected for the fiscal year ending June 30, 2016. The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended June 30, 2015.